The analysis revealed that FOXA1 expression showed no significant difference between tumor and normal control samples (Fig. 4A), while TFAP2C expression was significantly higher in BLCA tumor samples (Fig. 4D). This evidence concerns the gene FOXA1 and bladder transitional cell carcinoma.